1 Market Overview 1.1 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Type: 2019 Versus 2021 Versus 2026 1.2.2 Self-production API 1.2.3 Outsourcing of API 1.3 Market Analysis by Application 1.3.1 Overview: Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Application: 2019 Versus 2021 Versus 2026 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Drug Center 1.3.5 Other 1.4 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Size & Forecast 1.4.1 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales in Value (2016-2026)) 1.4.2 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales in Volume (2016-2026) 1.4.3 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Price by Type (2016-2026) & (USD/Pcs) 1.5 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Production Capacity Analysis 1.5.1 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Total Production Capacity (2016-2026) 1.5.2 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Production Capacity by Geographic Region 1.6 Market Drivers, Restraints and Trends 1.6.1 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Drivers 1.6.2 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Restraints 1.6.3 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Trends Analysis 2 Manufacturers Profiles 2.1 Gilead Sciences 2.1.1 Gilead Sciences Details 2.1.2 Gilead Sciences Major Business 2.1.3 Gilead Sciences Emtricitabine/Rilpivirine/Tenofovir Alafenamide Product and Services 2.1.4 Gilead Sciences Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021) 3 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Manufacturer 3.1 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales in Volume by Manufacturer (2019-2021e) 3.2 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Manufacturer (2019-2021e) 3.3 Key Manufacturer Market Position in Emtricitabine/Rilpivirine/Tenofovir Alafenamide 3.4 Market Concentration Rate 3.4.1 Top 3 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Manufacturer Market Share 3.4.2 Top 6 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Manufacturer Market Share 3.5 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Production Capacity by Company 3.6 Manufacturer by Geography: Head Office and Emtricitabine/Rilpivirine/Tenofovir Alafenamide Production Site 3.7 New Entrant and Capacity Expansion Plans 3.8 Mergers & Acquisitions 4 Market Analysis by Region 4.1 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Size by Region 4.1.1 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales in Volume by Region (2016-2026) 4.1.2 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Region (2016-2026) 4.2 North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (2016-2026) 4.3 Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (2016-2026) 4.4 Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (2016-2026) 4.5 South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (2016-2026) 4.6 Middle East and Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (2016-2026) 5 Market Segment by Type 5.1 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales in Volume by Type (2016-2026) 5.2 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Type (2016-2026) 5.3 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Price by Type (2016-2026) 6 Market Segment by Application 6.1 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales in Volume by Application (2016-2026) 6.2 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Application (2016-2026) 6.3 Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Price by Application (2016-2026) 7 North America by Country, by Type, and by Application 7.1 North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2016-2026) 7.2 North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2016-2026) 7.3 North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Size by Country 7.3.1 North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales in Volume by Country (2016-2026) 7.3.2 North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Country (2016-2026) 7.3.3 United States Market Size and Forecast (2016-2026) 7.3.4 Canada Market Size and Forecast (2016-2026) 7.3.5 Mexico Market Size and Forecast (2016-2026) 8 Europe by Country, by Type, and by Application 8.1 Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2016-2026) 8.2 Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2016-2026) 8.3 Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Size by Country 8.3.1 Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales in Volume by Country (2016-2026) 8.3.2 Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Country (2016-2026) 8.3.3 Germany Market Size and Forecast (2016-2026) 8.3.4 France Market Size and Forecast (2016-2026) 8.3.5 United Kingdom Market Size and Forecast (2016-2026) 8.3.6 Russia Market Size and Forecast (2016-2026) 8.3.7 Italy Market Size and Forecast (2016-2026) 9 Asia-Pacific by Country, by Type, and by Application 9.1 Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2016-2026) 9.2 Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2016-2026) 9.3 Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Size by Region 9.3.1 Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales in Volume by Region (2016-2026) 9.3.2 Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Region (2016-2026) 9.3.3 China Market Size and Forecast (2016-2026) 9.3.4 Japan Market Size and Forecast (2016-2026) 9.3.5 Korea Market Size and Forecast (2016-2026) 9.3.6 India Market Size and Forecast (2016-2026) 9.3.7 Southeast Asia Market Size and Forecast (2016-2026) 9.3.8 Australia Market Size and Forecast (2016-2026) 10 South America by Country, by Type, and by Application 10.1 South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2016-2026) 10.2 South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2016-2026) 10.3 South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Size by Country 10.3.1 South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales in Volume by Country (2016-2026) 10.3.2 South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Country (2016-2026) 10.3.3 Brazil Market Size and Forecast (2016-2026) 10.3.4 Argentina Market Size and Forecast (2016-2026) 11 Middle East & Africa by Country, by Type, and by Application 11.1 Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2016-2026) 11.2 Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2016-2026) 11.3 Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Size by Country 11.3.1 Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales in Volume by Country (2016-2026) 11.3.2 Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Country (2016-2026) 11.3.3 Turkey Market Size and Forecast (2016-2026) 11.3.4 Egypt Market Size and Forecast (2016-2026) 11.3.5 Saudi Arabia Market Size and Forecast (2016-2026) 11.3.6 South Africa Market Size and Forecast (2016-2026) 12 Sales Channel, Distributors, Traders and Dealers 12.1 Sales Channel 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.2 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Typical Distributors 12.3 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Typical Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Research Process and Data Source 14.3 Disclaimer

List of Tables Table 1. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Type, (USD Million), 2021-2026 Table 2. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Application, (USD Million), 2021-2026 Table 3. Gilead Sciences Basic Information, Manufacturing Base and Competitors Table 4. Gilead Sciences Major Business Table 5. Gilead Sciences Emtricitabine/Rilpivirine/Tenofovir Alafenamide Product and Services Table 6. Gilead Sciences Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 7. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Manufacturer (2019-2021e) & (K Pcs) Table 8. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Manufacturer (2019-2021e) & (USD Million) Table 9. Market Position of Manufacturers in Emtricitabine/Rilpivirine/Tenofovir Alafenamide, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020 Table 10. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Production Capacity by Company, (K Pcs): 2020 VS 2021 Table 11. Head Office and Emtricitabine/Rilpivirine/Tenofovir Alafenamide Production Site of Key Manufacturer Table 12. Emtricitabine/Rilpivirine/Tenofovir Alafenamide New Entrant and Capacity Expansion Plans Table 13. Emtricitabine/Rilpivirine/Tenofovir Alafenamide Mergers & Acquisitions in the Past Five Years Table 14. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Region (2016-2021e) & (K Pcs) Table 15. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Region (2021-2026) & (K Pcs) Table 16. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Region (2016-2021e) & (USD Million) Table 17. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Region (2021-2026) & (USD Million) Table 18. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2016-2021e) & (K Pcs) Table 19. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2021-2026) & (K Pcs) Table 20. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Type (2016-2021e) & (USD Million) Table 21. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Type (2021-2026) & (USD Million) Table 22. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Price by Type (2016-2021e) & (USD/Pcs) Table 23. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Price by Type (2021-2026) & (USD/Pcs) Table 24. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2016-2021e) & (K Pcs) Table 25. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2021-2026) & (K Pcs) Table 26. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Application (2016-2021e) & (USD Million) Table 27. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Application (2021-2026) & (USD Million) Table 28. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Price by Application (2016-2021e) & (USD/Pcs) Table 29. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Price by Application (2021-2026) & (USD/Pcs) Table 30. North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Country (2016-2021e) & (K Pcs) Table 31. North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Country (2021-2026) & (K Pcs) Table 32. North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Country (2016-2021e) & (USD Million) Table 33. North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Country (2021-2026) & (USD Million) Table 34. North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2016-2021e) & (K Pcs) Table 35. North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2021-2026) & (K Pcs) Table 36. North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2016-2021e) & (K Pcs) Table 37. North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2021-2026) & (K Pcs) Table 38. Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Country (2016-2021e) & (K Pcs) Table 39. Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Country (2021-2026) & (K Pcs) Table 40. Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Country (2016-2021e) & (USD Million) Table 41. Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Country (2021-2026) & (USD Million) Table 42. Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2016-2021e) & (K Pcs) Table 43. Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2021-2026) & (K Pcs) Table 44. Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2016-2021e) & (K Pcs) Table 45. Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2021-2026) & (K Pcs) Table 46. Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Region (2016-2021e) & (K Pcs) Table 47. Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Region (2021-2026) & (K Pcs) Table 48. Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Region (2016-2021e) & (USD Million) Table 49. Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Region (2021-2026) & (USD Million) Table 50. Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2016-2021e) & (K Pcs) Table 51. Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2021-2026) & (K Pcs) Table 52. Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2016-2021e) & (K Pcs) Table 53. Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2021-2026) & (K Pcs) Table 54. South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Country (2016-2021e) & (K Pcs) Table 55. South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Country (2021-2026) & (K Pcs) Table 56. South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Country (2016-2021e) & (USD Million) Table 57. South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Country (2021-2026) & (USD Million) Table 58. South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2016-2021e) & (K Pcs) Table 59. South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2021-2026) & (K Pcs) Table 60. South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2016-2021e) & (K Pcs) Table 61. South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2021-2026) & (K Pcs) Table 62. Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Country (2016-2021e) & (K Pcs) Table 63. Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Country (2021-2026) & (K Pcs) Table 64. Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Country (2016-2021e) & (USD Million) Table 65. Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue by Country (2021-2026) & (USD Million) Table 66. Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2016-2021e) & (K Pcs) Table 67. Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Type (2021-2026) & (K Pcs) Table 68. Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2016-2021e) & (K Pcs) Table 69. Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales by Application (2021-2026) & (K Pcs) Table 70. Direct Channel Pros & Cons Table 71. Indirect Channel Pros & Cons Table 72. Emtricitabine/Rilpivirine/Tenofovir Alafenamide Typical Distributors Table 73. Emtricitabine/Rilpivirine/Tenofovir Alafenamide Typical Customers List of Figures Figure 1. Emtricitabine/Rilpivirine/Tenofovir Alafenamide Picture Figure 2. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Type in 2020 Figure 3. Self-production API Figure 4. Outsourcing of API Figure 5. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Application in 2020 Figure 6. Hospital Figure 7. Clinic Figure 8. Drug Center Figure 9. Other Figure 10. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026 Figure 11. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Size and Forecast (2016-2026) & (USD Million) Figure 12. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales (2016-2026) & (K Pcs) Figure 13. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Price by Type (2016-2026) & (USD/Pcs) Figure 14. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Production Capacity (2016-2026) & (K Pcs) Figure 15. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Production Capacity by Geographic Region: 2020 VS 2021 Figure 16. Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Drivers Figure 17. Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Restraints Figure 18. Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Trends Figure 19. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Manufacturer in 2020 Figure 20. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Manufacturer in 2020 Figure 21. Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3) Figure 22. Top 3 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Manufacturer (Revenue) Market Share in 2020 Figure 23. Top 6 Emtricitabine/Rilpivirine/Tenofovir Alafenamide Manufacturer (Revenue) Market Share in 2020 Figure 24. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Region (2016-2026) Figure 25. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Region (2016-2026) Figure 26. North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (2016-2026) & (USD Million) Figure 27. Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (2016-2026) & (USD Million) Figure 28. Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (2016-2026) & (USD Million) Figure 29. South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (2016-2026) & (USD Million) Figure 30. Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue (2016-2026) & (USD Million) Figure 31. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Type (2016-2026) Figure 32. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Type (2016-2026) Figure 33. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Price by Type (2016-2026) & (USD/Pcs) Figure 34. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Application (2016-2026) Figure 35. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Application (2016-2026) Figure 36. Global Emtricitabine/Rilpivirine/Tenofovir Alafenamide Price by Application (2016-2026) & (USD/Pcs) Figure 37. North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Type (2016-2026) Figure 38. North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Application (2016-2026) Figure 39. North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Country (2016-2026) Figure 40. North America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Country (2016-2026) Figure 41. United States Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 42. Canada Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 43. Mexico Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 44. Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Type (2016-2026) Figure 45. Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Application (2016-2026) Figure 46. Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Country (2016-2026) Figure 47. Europe Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Country (2016-2026) Figure 48. Germany Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 49. France Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 50. United Kingdom Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 51. Russia Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 52. Italy Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 53. Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Region (2016-2026) Figure 54. Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Application (2016-2026) Figure 55. Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Region (2016-2026) Figure 56. Asia-Pacific Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Region (2016-2026) Figure 57. China Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 58. Japan Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 59. Korea Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 60. India Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 61. Southeast Asia Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 62. Australia Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 63. South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Type (2016-2026) Figure 64. South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Application (2016-2026) Figure 65. South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Country (2016-2026) Figure 66. South America Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Country (2016-2026) Figure 67. Brazil Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 68. Argentina Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 69. Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Type (2016-2026) Figure 70. Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Application (2016-2026) Figure 71. Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Sales Market Share by Country (2016-2026) Figure 72. Middle East & Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue Market Share by Country (2016-2026) Figure 73. Turkey Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 74. Egypt Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 75. Saudi Arabia Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 76. South Africa Emtricitabine/Rilpivirine/Tenofovir Alafenamide Revenue and Growth Rate (2016-2026) & (USD Million) Figure 77. Sales Channel: Direct Channel vs Indirect Channel Figure 78. Methodology Figure 79. Research Process and Data Source

Gilead Sciences